NCT03656250View on ClinicalTrials.gov

Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

November 18, 2017

Primary Completion Date

November 19, 2018

Study Completion Date

November 19, 2018

Conditions
Nasopharyngeal Cancer
Interventions
DIAGNOSTIC_TEST

PET/CT scans

(approximately 18 mSv/scan) and perform maximum two additional PET/MR scans; one immediately after the first stage of treatment and another one immediately after the second stage if the 3-month chemotherapy is given).

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03656250 - Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI | Biotech Hunter | Biotech Hunter